On February 11, the New York Mets confirmed that shortstop Francisco Lindor will have surgery to treat a hamate bone injury, as announced by manager Carlos Mendoza. While the team has not officially ruled him out for Opening Day, there is significant uncertainty regarding his availability as the season begins.
Initial Evaluation and Recovery Timeline
The investigation into Lindor’s hamate injury was first disclosed on February 10 by David Stearns, the Mets’ president of baseball operations. He explained that if surgery is necessary, Lindor faces an estimated six-week recovery period. Despite this, Stearns expressed optimism that Lindor could still return in time for the start of the season. The Mets are scheduled to open their season against the Pittsburgh Pirates on March 26.
Lindor’s Recent Injury History and Current Condition
Earlier in the offseason, Lindor underwent a debridement procedure on his right elbow, which prevented his participation in the 2026 World Baseball Classic due to insurance complications. This hamate bone issue marks a new challenge; he has been experiencing a stress reaction in the bone over the past several days. Hamate injuries are known to affect hitters’ power, and Lindor has consistently been a strong power hitter, recording at least 30 home runs each of the past three seasons.
Prior to this, Lindor’s health record with the Mets has been strong. Aside from missing a month due to an oblique strain in 2021, he has maintained impressive durability, playing in at least 152 games over the last four seasons and accumulating over 680 plate appearances annually, including a league-leading 732 last year.
Impact on Mets’ Roster and Possible Replacements
Should Lindor be sidelined for an extended period, the Mets have several options to fill the shortstop position. Bo Bichette, primarily acquired to play third base, could shift back to his natural shortstop role despite recent declines in his defensive performance. Ronny Mauricio, who spent most of his minor league career at shortstop but has mostly played third base in the majors because of Lindor’s presence, also remains an option. Additionally, Vidal Bruján is listed on the Mets’ 40-man roster and has recent experience at shortstop.
Offensive Challenges Ahead Without Lindor
Losing Lindor’s offensive contributions would create a significant gap in a lineup that is already undergoing changes for the 2026 season. Key players such as Brandon Nimmo, Pete Alonso, and Cedric Mullins have all departed, and new additions like Marcus Semien, Jorge Polanco, Luis Robert Jr., and Bo Bichette are expected to play integral roles. Maintaining Lindor’s powerful bat will be crucial in this evolving lineup.
Outlook for the Mets Moving Forward
Francisco Lindor’s pending hamate surgery and potential time away from the field contribute to a degree of uncertainty for the Mets as they prepare for the upcoming season. How quickly Lindor recovers will significantly influence the team’s early performance and roster decisions. The Mets’ ability to adapt and utilize their internal options will be critical in navigating this setback while integrating new faces into their offense.
News: Francisco Lindor will indeed undergo surgery on his left hand. He's having it today. The expected recovery timetable should take him right up to Opening Day.
— Anthony DiComo (@AnthonyDiComo) February 11, 2026
Francisco Lindor will be evaluated for a stress reaction in his left hamate bone, David Stearns said. Surgery is possible and would include a six-week recovery. Stearns said he’s confident Lindor could be ready for opening day if he undergoes the surgery.
— Jorge Castillo (@jorgecastillo) February 10, 2026
